TTGT TechTarget, Inc. Insider Trading

Director FLASCHEN purchases 20.0K shares of TTGT at $5.97; stock down 81.7% from $33.19 high, company unprofitable.

Director David J Flaschen purchased 20,000 shares at $5.97 on 2025-09-12, establishing an initial stake in TechTarget. The purchase occurs at a price that is 81.7% below the 52-week high of $33.19, in a company posting net income of $-398.7M against quarterly revenue of $119.9M. Flaschen's cross-ticker track record shows 10 prior buys with an average 90-day return of 4.3%, but his 10 prior sales were poorly timed (average 90-day return of 4.9%, indicating the stock rose after his exits). The present transaction represents a new director purchase at depressed valuation, though the company's sustained unprofitability and recent 8.8% 90-day decline warrant investor scrutiny of the underlying business fundamentals alongside this insider activity.

CEO Nugent Gary John bought 4,200 shares of TTGT at $5.85 on 2025-09-12, his first holding; stock -82.0% from 52-week high.

Nugent Gary John, CEO of TechTarget, purchased 4,200 shares at $5.85 on 2025-09-12, establishing an initial position from zero shares. The transaction occurs in a weak price environment: the stock trades at $5.97, down 82.0% from its 52-week high of $33.19, and has declined 15.6% over the prior 90 days. The company is unprofitable, reporting net income of $-398.7M in its most recent full fiscal year, though annual revenue growth remains positive at 13.0%. The modest purchase size ($24.6K) and deteriorated valuation create limited interpretive clarity about CEO conviction versus circumstantial factors.

Director Michael Sean Griffey purchased 148,248 shares across 20 transactions for $3,542,666.63 from Dec 3–20 at blended average of $23.90; stock now down 52.4% from 52-week high.

Michael Sean Griffey, a TechTarget director, executed 20 separate share purchases totaling 148.2K shares for $3.5M between December 3–20, 2024, establishing a zero-to-148.2K share position. The purchases spanned a price range from $20.00 to $27.00 with a blended average price of $23.90, yet the stock has since declined to $18.88 (52.4% below the 52-week high of $39.66). The director's sustained buying across multiple dates and price points over a concentrated three-week window occurs in a company showing zero revenue and zero net income for the latest quarter, with a market cap of $18.9K, raising material questions about the company's business status and operational condition. The significant capital commitment from a director during this period, combined with the company's apparent financial vacuum and the subsequent steep price decline, warrants investor attention to the underlying company fundamentals and the circumstances motivating this accumulation.